A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL patients who are not eligible for autologous stem cell transplant, Roche ...

An interdisciplinary team working on balls of human neurons called organoids wanted to scale up their efforts and take on ...

Using new tech to observe real-time changes in microbial gut activity, researchers find eating in preferred circadian windows ...

ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...

Gov. Jim Pillen celebrates a win over lab-grown meat, ceremonially signing a bill in O'Neill banning the sale and production ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

MIT gave photosynthesis a boost by evolving rubisco to work faster, raising hopes for higher crop yields and more efficient ...

Eight children in the UK have been spared from devastating genetic diseases thanks to a new three-person in vitro ...

Scientists have converted food waste into biodegradable plastic using bacteria, offering a dual fix for global food and ...

Researchers report that eight healthy babies were born with the help of an experimental technique that uses DNA from three ...

The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing schedule that includes intravenous administration, step-up dosing, and ...